Impact of glioma peritumoral edema, tumor size, and tumor location on alternating electric fields (AEF) therapy in realistic 3D rat glioma models: a computational study

Phys Med Biol. 2024 Apr 4;69(8). doi: 10.1088/1361-6560/ad2e6c.

Abstract

Objective.Alternating electric fields (AEF) therapy is a treatment modality for patients with glioblastoma. Tumor characteristics such as size, location, and extent of peritumoral edema may affect the AEF strength and distribution. We evaluated the sensitivity of the AEFs in a realistic 3D rat glioma model with respect to these properties.Approach.The electric properties of the peritumoral edema were varied based on calculated and literature-reported values. Models with different tumor composition, size, and location were created. The resulting AEFs were evaluated in 3D rat glioma models.Main results.In all cases, a pair of 5 mm diameter electrodes induced an average field strength >1 V cm-1. The simulation results showed that a negative relationship between edema conductivity and field strength was found. As the tumor core size was increased, the average field strength increased while the fraction of the shell achieving >1.5 V cm-1decreased. Increasing peritumoral edema thickness decreased the shell's mean field strength. Compared to rostrally/caudally, shifting the tumor location laterally/medially and ventrally (with respect to the electrodes) caused higher deviation in field strength.Significance.This study identifies tumor properties that are key drivers influencing AEF strength and distribution. The findings might be potential preclinical implications.

Keywords: alternating electric fields (AEF); computational modeling; edema; glioblastoma; sensitivity analysis; small animals; tumor treating fields (TTFields).

MeSH terms

  • Animals
  • Brain Neoplasms* / pathology
  • Brain Neoplasms* / therapy
  • Electric Stimulation Therapy* / methods
  • Glioblastoma* / pathology
  • Glioma* / therapy
  • Humans
  • Lymphokines*
  • Rats

Substances

  • allogenic effect factor
  • Lymphokines